Scott Bembenek

Scott Bembenek is the visionary Founder and CEO of Denovicon Therapeutics, leading the charge in revolutionizing drug discovery. With a robust background in Computer-Aided Drug Discovery, AI, Machine Learning, Molecular Modeling, and Biophysics, he has crafted a best-in-class computational drug discovery platform. This platform integrates cutting-edge technologies such as AI, machine learning, gen...